{"id":"W2000868686","doi":"10.5414/cp201687","title":"Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions","year":2012,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"BioPhage Pharma (Canada); Pharmaxis (Canada)","funders":"","keywords":"Bioequivalence; Rosuvastatin; Pharmacokinetics; Medicine; Tolerability; Crossover study; Confidence interval; Pharmacology; Rosuvastatin Calcium; Adverse effect; Dosing; Internal medicine; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004341067,0.001390587,0.003590293,0.0006008513,0.000596654,0.0009176728,0.0006542515,0.001592168,0.002948462],"category_scores_gemma":[0.003211625,0.0008762,0.001190831,0.0004509902,0.001417741,0.001135984,0.0004246512,0.001542515,0.0008226544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004517017,"about_ca_system_score_gemma":0.0007839525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000495879,"about_ca_topic_score_gemma":0.0004860496,"domain_scores_codex":[0.9971772,0.001364983,0.0002381437,0.0005987064,0.0004081703,0.0002127962],"domain_scores_gemma":[0.9984724,0.0003271152,0.0003865386,0.0003049576,0.0002030491,0.0003060034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7902991,0.06006286,0.002917351,0.0005483727,0.0009035569,0.00009990524,0.0005982718,0.0004888168,0.1201818,0.0001690919,0.000524947,0.02320587],"study_design_scores_gemma":[0.1039367,0.8540818,0.02494134,0.00002450698,0.0008741589,0.0001601174,0.0001687143,0.001525066,0.01261963,0.0001652882,0.00142609,0.0000765585],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963445,0.000444567,0.001097574,0.00006088783,0.0001110556,0.001256189,0.0002966789,0.00005900595,0.0003294847],"genre_scores_gemma":[0.9919458,0.0003689991,0.003428498,0.0002183247,0.0001729725,0.002133819,0.0004507154,0.00002885845,0.001252051],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004341067,"threshold_uncertainty_score":0.02295804,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1491367167304826,"score_gpt":0.4978930408787807,"score_spread":0.348756324148298,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}